{
  "pmcid": "1283103",
  "sha256": "c207cbdcc77d8e89b71ae7dd3d545de8510f62b271546460ea3958166569a607",
  "timestamp_utc": "2025-11-09T15:46:34.047060+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.760769230769231,
    "reading_ease": 19.559230769230822,
    "word_count": 52
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "ketamine 10 mg and nefopam 20 mg comparably potentiate opioid analgesia"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "reducing opioid need by approximately 40%"
      },
      "Harms": {
        "score": 1,
        "evidence": "Ketamine administration was associated with sedation whereas nefopam produced tachycardia and sweating."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 4,
    "max_score": 25
  }
}